SOURCE: United Consortium Ltd.

December 14, 2017 13:37 ET

UCL Nears Completion of OTC Listing Upgrade

Company Provides Shareholder Update

TAMPA, FL--(Marketwired - December 14, 2017) - United Consortium Ltd. (OTC PINK: UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space, today announced that it has nearly completed more than two years of financial statements and other related documents necessary to complete its listing upgrade to pink current status on OTC Markets.

Today UCL is finishing its financial statements and initial disclosure document as required by OTC Markets in order to complete the upgrade of its stock listing to pink current information status. UCL expects to be able to file these documents, pending legal review, in the next week or so. At such time UCL will immediately reschedule its shareholder conference call to review its current projects and ventures as summarized below:

Block Chain Project - UCL is currently is the process of designing and building a personal health records (PHR) block chain based business. The new platform will enable patients to gain control over their personal health records as well as who sees them, and how they are used. Expected beta launch for this project is Q1 2018.

Lawyers Network - UCL is developing an app and new client acquisition platform for its network of more than 100 top level legal focused domain names such as DUILawyers.com, ImmigrationAttorney.com, PersonalInjuries.com, CriminalAttorneys.com and more than 100 other legal brands. Currently soft launched via third party platform integration. UCL expects revenue generation in Q1 2018.

Digital Cannabis Project - UCL is developing what it believes will be an exciting new digital Cannabis focused venture scheduled for release in Q1 of 2018 as well. This project will not be discussed in detail until it is launched for competitive reasons.

About United Consortium Ltd. (UCL)

UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.

Forward-Looking Statements

This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.'s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.

Contact Information

  • For additional information contact:
    Scott Gallagher
    727-417-7807